Skip to content

EEG Detection of Delirium

Prefrontal EEG Early Detection of Delirium in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04797052
Acronym
VEEGilance
Enrollment
234
Registered
2021-03-15
Start date
2021-04-05
Completion date
2023-01-30
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Delirium

Keywords

Post operative delirium, Older Adults, Electroencephalography

Brief summary

VEEGix is a portable device developed by NeuroServo for simplifying electroencephalograms at the bedside. It is an easy-to-use device that only requires the operator to place an adhesive strip of electrodes on the patient's forehead, connected to the device. The goal of this study is to determine EEG thresholds for the diagnostic of delirium. Methods : This prospective observational study includes patients undergoing orthopedic or degestive surgery. Each subject will have an EEG reading before surgery and twice daily after surgery until discharge or up to 5 days. Patients will be monitored for post operative delirium using the 3D-Confusion Assessment Method. Delirium diagnostic will be confirmed by a geriatrician. EEG relative power reading will be compared between patient with and without a delirium diagnostic.

Interventions

DEVICEPrefrontal EEG (VEEGix by NeuroServo)

Prefrontal EEG reading

Sponsors

TransMedTech Institute
CollaboratorUNKNOWN
Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Prospective observational study

Eligibility

Sex/Gender
ALL
Age
65 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

* 65 years and older * Had a orthopedic or digestive surgery * Good undersanding of French or English * Consent to participate in the study

Exclusion criteria

* History of seizure or epilepsia * Structural brain damage * intelectual deiciency * Severe major neurocognitive disorder * incapacity to respond to the questionnaire * Hospitalised in intensive care or intubated

Design outcomes

Primary

MeasureTime frameDescription
Difference of relative power of delta and theta brain wavesup to five days after the operationDifference between group with and without delirium

Secondary

MeasureTime frameDescription
Difference of relative power of beta and alpha brain wavesup to five days after the operationDifference between group with and without delirium
describe the presence of artefactsup to five days after the operationExamine the EEG reading for artefacts

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026